» Articles » PMID: 3305357

Local and Systemic Antibody Responses Accompany Spontaneous Resolution of Experimental Cystitis in Cynomolgus Monkeys

Overview
Journal Infect Immun
Date 1987 Sep 1
PMID 3305357
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Cynomolgus monkeys were infected intravesically with two different strains of uropathogenic Escherichia coli. A quantitative enzyme-linked immunosorbent assay method was used to monitor secretory and serum immune responses to the induced cystitis. Anti-E. coli secretory immunoglobulin A (sIgA) and IgG urinary antibodies were generated as a result of the cystitis. Urinary sIgA levels against the E. coli strains tested were highest at 25 to 31 days after cystitis induction, and urinary IgG levels were highest at 31 to 45 days after induction. Anti-E. coli IgM was not detected in the urine. The antibody response in serum was characterized by IgM, IgG, and IgA immunoglobulin production. IgM levels in serum rose at 14 days after cystitis induction and were sustained for another 1 to 2 weeks. Increases in serum IgG levels began at 7 to 21 days of infection and persisted in some cases for up to 70 days. Serum IgA to the infecting E. coli was produced within 1 week after cystitis induction and remained at elevated levels throughout the course of the cystitis. These results demonstrate the capacity of primates to spontaneously resolve a cystitis and to mount both local and systemic immune responses against the infecting bacteria.

Citing Articles

A cynomolgus monkey urinary tract infection model confirms efficacy of new FimH vaccine candidates.

Chorro L, Ciolino T, Torres C, Illenberger A, Aglione J, Corts P Infect Immun. 2024; 92(10):e0016924.

PMID: 39297649 PMC: 11475676. DOI: 10.1128/iai.00169-24.


Bladder-draining lymph nodes support germinal center B cell responses during urinary tract infection in mice.

Hawas S, Vagenas D, Haque A, Totsika M Infect Immun. 2023; 91(11):e0031723.

PMID: 37882531 PMC: 10652902. DOI: 10.1128/iai.00317-23.


A sublingual nanofiber vaccine to prevent urinary tract infections.

Kelly S, Votaw N, Cossette B, Wu Y, Shetty S, Shores L Sci Adv. 2022; 8(47):eabq4120.

PMID: 36417519 PMC: 9683704. DOI: 10.1126/sciadv.abq4120.


Macrophages Subvert Adaptive Immunity to Urinary Tract Infection.

Mora-Bau G, Platt A, van Rooijen N, Randolph G, Albert M, Ingersoll M PLoS Pathog. 2015; 11(7):e1005044.

PMID: 26182347 PMC: 4504509. DOI: 10.1371/journal.ppat.1005044.


A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs).

Lassek C, Burghartz M, Chaves-Moreno D, Otto A, Hentschker C, Fuchs S Mol Cell Proteomics. 2015; 14(4):989-1008.

PMID: 25673765 PMC: 4390275. DOI: 10.1074/mcp.M114.043463.


References
1.
Roberts J, Suarez G, Kaack B, Kallenius G, Svenson S . Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux. J Urol. 1985; 133(6):1068-75. DOI: 10.1016/s0022-5347(17)49382-7. View

2.
Svanborg Eden C, Kulhavy R, Marild S, Prince S, Mestecky J . Urinary immunoglobulins in healthy individuals and children with acute pyelonephritis. Scand J Immunol. 1985; 21(4):305-13. DOI: 10.1111/j.1365-3083.1985.tb01435.x. View

3.
Rene P, Dinolfo M, Silverblatt F . Serum and urogenital antibody responses to Escherichia coli pili in cystitis. Infect Immun. 1982; 38(2):542-7. PMC: 347772. DOI: 10.1128/iai.38.2.542-547.1982. View

4.
Uehling D, Mizutani K, Balish E . Effect of immunization of bacterial adherence to urothelium. Invest Urol. 1978; 16(2):145-7. View

5.
Stamey T, Wehner N, Mihara G, Condy M . The immunologic basis of recurrent bacteriuria: role of cervicovaginal antibody in enterobacterial colonization of the introital mucosa. Medicine (Baltimore). 1978; 57(1):47-56. DOI: 10.1097/00005792-197801000-00003. View